Step 1 topics → Reproductive → Adenomyosis

Adenomyosis

USMLE Step 1 trap: Conflates adenomyosis with endometriosis due to shared ectopic endometrial tissue. Adenomyosis is endometrial glands and stroma within the myometrium (causing a diffusely enlarged, boggy uterus), while endometriosis involves implants outside the uterus entirely.

Adenomyosis is the presence of endometrial glands and stroma within the myometrium — and USMLE Step 1 tests it primarily by forcing you to distinguish it from endometriosis, where students most commonly go wrong. The invasion causes the uterine muscle to hypertrophy and the whole uterus to enlarge symmetrically, giving you that classic 'boggy uterus' on exam. The patient presents with heavy, painful periods and a soft, diffusely enlarged uterus on bimanual exam. The exam also hits management questions that probe whether you know what 'definitive' actually means — and GnRH agonists are not it.

The trickiest part of this topic is the endometriosis overlap. Both involve ectopic endometrial tissue, so students conflate them. But the location is everything: adenomyosis stays within the uterine wall (myometrium), while endometriosis plants itself outside the uterus — on ovaries, peritoneum, bowel. The presentations differ too: adenomyosis skews toward multiparous women in their 40s–50s with a boggy enlarged uterus, while endometriosis hits younger, often nulliparous women with cyclic pelvic pain and no uterine enlargement.

The management angle is where USMLE Step 1 likes to set a trap. GnRH agonists suppress symptoms by inducing a hypoestrogenic state, but this is temporary — symptoms return once you stop. Hysterectomy is the only definitive cure. If a question asks about definitive treatment and you're tempted to pick a hormonal option, slow down and re-read.

From real student decks
41%have cards covering this topic
24%have mature cards

Common misconceptions

Common mistake
Wrong: Adenomyosis and endometriosis are the same condition because both involve ectopic endometrial tissue.
Right: Adenomyosis is endometrial glands and stroma within the myometrium (causing a diffusely enlarged, boggy uterus), while endometriosis involves implants outside the uterus entirely.
Both conditions involve ectopic endometrial tissue, but the location makes them completely different diseases. Adenomyosis is confined to inside the uterine wall (myometrium), producing a diffusely enlarged, boggy uterus. Endometriosis involves implants entirely outside the uterus — on the ovaries, pelvic peritoneum, or bowel — and does not cause uterine enlargement. When you see 'boggy uterus' in a stem, that's adenomyosis; when you see cyclic pelvic pain with normal uterine size or an ovarian cyst (endometrioma), think endometriosis.
Common mistake
Wrong: GnRH agonists are the definitive cure for adenomyosis.
Right: GnRH agonists provide temporary symptom relief in adenomyosis but symptoms recur after stopping; hysterectomy is the only definitive cure.
GnRH agonists work by suppressing estrogen, which causes adenomyotic tissue to atrophy — but the tissue is still there. Once you stop the medication and estrogen returns, symptoms come back. 'Definitive' means the condition cannot recur, and that only happens when the uterus is removed entirely. Hysterectomy is the definitive treatment for adenomyosis; GnRH agonists are a bridge or temporizing measure, not a cure.
Common mistake
Wrong: Adenomyosis typically affects nulliparous young women, similar to endometriosis.
Right: Adenomyosis typically affects multiparous women in their 40s–50s, in contrast to endometriosis which more commonly affects younger, often nulliparous women.
Applying the endometriosis profile (young, nulliparous) to adenomyosis is a common error. Adenomyosis is associated with prior uterine instrumentation or childbirth — hence the multiparous, older (40s–50s) patient profile. Endometriosis, by contrast, often affects women in their 20s–30s who may not have had children. When the vignette says '48-year-old woman, 3 prior vaginal deliveries, heavy periods, soft enlarged uterus,' that profile is pointing you toward adenomyosis, not endometriosis.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the definition of adenomyosis — endometrial glands and stroma within the myometrium — and identify the typical patient as a multiparous woman in her 40s–50s presenting with heavy periods, dysmenorrhea, and a soft, symmetrically enlarged uterus on exam.
  2. Distinguish adenomyosis from endometriosis based on location of ectopic tissue, patient profile, and physical exam findings — the exam will often present both as answer choices in the same vignette.
  3. Understand the difference between medical management (GnRH agonists, OCPs, progestins — all temporary) and definitive management (hysterectomy) for adenomyosis, and know when each is appropriate.

Can you avoid these mistakes?

A 46-year-old G3P3 woman presents with heavy menstrual bleeding and pelvic pain for 2 years. On bimanual exam, her uterus is soft, symmetrically enlarged, and tender. Ultrasound shows diffuse uterine enlargement with no discrete masses. What is the most likely diagnosis, and what finding on pathology would confirm it?
A patient with adenomyosis is started on a GnRH agonist and her symptoms resolve completely. She asks if she can stop the medication after 6 months. What do you tell her about what will happen, and what would be the only way to permanently eliminate her symptoms?
You have two patients: one is a 28-year-old nulliparous woman with cyclic pelvic pain and a 4 cm left ovarian cyst; the other is a 49-year-old G4P4 with menorrhagia and a soft, enlarged uterus. Which diagnosis fits each patient, and what is the key anatomical distinction between the two conditions?
A Step 1 question asks about a multiparous woman in her late 40s with heavy periods and a 'boggy uterus.' The answer choices include endometriosis, adenomyosis, leiomyoma, and endometrial polyp. What features of the stem point you toward adenomyosis over the other options?

Related topics

Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →